RecruitingACTRN12609000011280

Sub-chronic administration of the selective serotonin reuptake inhibitor escitalopram in healthy volunteers: drug initiation effects and the role of serotonin in experimental anxiety.

The effect in healthy volunteers of administration of the selective serotonin reuptake inhibitor escitalopram (10 mg/day for 3 weeks) vs. placebo on drug initiation effects and experimentally-induced anxiety.


Sponsor

University of Western Australia

Enrollment

28 participants

Start Date

Aug 10, 2008

Study Type

Interventional

Conditions

Summary

The purpose of this study is to investigate whether the effect of selective serotonin reuptake inhibitors seen when used to treat anxiety are related to the drug, or to the fact that the people have an anxiety disorder. We expect that we will see "jitteriness" when healthy volunteers start taking the medication, and that the medication will reduce anxiety brought on by an experimental challenge in people who do not have an anxiety disorder.


Eligibility

Sex: Both males and femalesMin Age: 18 YearssMax Age: 65 Yearss

Plain Language Summary

Simplified for easier understanding

This study is for healthy adults who want to help researchers understand how a common type of antidepressant medication (escitalopram, an SSRI) affects anxiety and mood in people who do not have an anxiety disorder. Many people starting SSRIs feel more anxious or "jittery" in the first few weeks, before the medication's benefits kick in. This study explores whether this early jitteriness also happens in healthy people, and whether the medication can reduce anxiety brought on by an experimental challenge test. You may be eligible if: - You are a healthy adult between 18 and 65 years of age - You have no current or past history of anxiety, depression, or any other mental illness You may NOT be eligible if: - You have or have had a mental illness - You have previously taken or are currently taking SSRI medication - You are pregnant or breastfeeding - You have a serious medical condition - You have had a significant head injury - You have a history of drug abuse or dependence Talk to your doctor about whether this trial might be right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

escitalopram (10 mg/day for 3 weeks, oral) tryptophan depletion

escitalopram (10 mg/day for 3 weeks, oral) tryptophan depletion


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12609000011280